<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheepurupalli L</submitter><funding>Science and Engineering Research Board</funding><pagination>614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5388697</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>The emergence and spread of multi-drug resistant (MDR) especially carbapenem-resistant &lt;i>Klebsiella pneumoniae&lt;/i> is a major emerging threat to public health, leading to excess in mortality rate as high as 50-86%. MDR &lt;i>K. pneumoniae&lt;/i> manifests all broad mechanisms of drug resistance, hence development of new drugs to treat MDR &lt;i>K. pneumoniae&lt;/i> infection has become a more relevant question in the scientific community. In the present study a potential &lt;i>Streptomyces&lt;/i> sp. ASK2 was isolated from rhizosphere soil of medicinal plant. The multistep HPLC purification identified the active principle exhibiting antagonistic activity against MDR &lt;i>K. pneumoniae&lt;/i>. The purified compound was found to be an aromatic compound with aliphatic side chain molecule having a molecular weight </pubmed_abstract><journal>Frontiers in microbiology</journal><pubmed_title>Bioactive Molecule from &lt;i>Streptomyces&lt;/i> sp. Mitigates MDR &lt;i>Klebsiella pneumoniae&lt;/i> in Zebrafish Infection Model.</pubmed_title><pmcid>PMC5388697</pmcid><funding_grant_id>SR/SO/HS-0073/2012</funding_grant_id><pubmed_authors>Rathore SS</pubmed_authors><pubmed_authors>Cheepurupalli L</pubmed_authors><pubmed_authors>Ramakrishnan J</pubmed_authors><pubmed_authors>Raman T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bioactive Molecule from &lt;i>Streptomyces&lt;/i> sp. Mitigates MDR &lt;i>Klebsiella pneumoniae&lt;/i> in Zebrafish Infection Model.</name><description>The emergence and spread of multi-drug resistant (MDR) especially carbapenem-resistant &lt;i>Klebsiella pneumoniae&lt;/i> is a major emerging threat to public health, leading to excess in mortality rate as high as 50-86%. MDR &lt;i>K. pneumoniae&lt;/i> manifests all broad mechanisms of drug resistance, hence development of new drugs to treat MDR &lt;i>K. pneumoniae&lt;/i> infection has become a more relevant question in the scientific community. In the present study a potential &lt;i>Streptomyces&lt;/i> sp. ASK2 was isolated from rhizosphere soil of medicinal plant. The multistep HPLC purification identified the active principle exhibiting antagonistic activity against MDR &lt;i>K. pneumoniae&lt;/i>. The purified compound was found to be an aromatic compound with aliphatic side chain molecule having a molecular weight </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2026-04-08T16:52:54.046Z</modification><creation>2019-03-27T02:41:04Z</creation></dates><accession>S-EPMC5388697</accession><cross_references><pubmed>28446900</pubmed><doi>10.3389/fmicb.2017.00614</doi></cross_references></HashMap>